Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Pharmaceuticals & Biotechnology | Small Cap
Health Score : 7.50Medplus Health Services Ltd demonstrates a mixed financial performance. The company shows strong growth and profitability, supported by solid solvency and liquidity. Growth is fueled by impressive revenue and earnings per share increases. Profitability metrics such as return on assets and gross profit margin also indicate healthy financial performance. Solvency ratios suggest a stable financial structure. However, efficiency and coverage ratios reveal some areas of concern. Capital expenditure management and dividend policies need attention. The company's liquidity position is strong with good current and cash ratios. Overall, Medplus exhibits sound financial health, but needs to address certain operational inefficiencies and coverage weaknesses to sustain long-term growth and stability. The company's robust performance in growth and profitability is a positive sign for future prospects.
Health Score : 7.50Medplus Health Services Ltd demonstrates a mixed financial performance. The company shows strong growth and profitability, supported by solid solvency and liquidity. Growth is fueled by impressive revenue and earnings per share increases. Profitability metrics such as return on assets and gross profit margin also indicate healthy financial performance. Solvency ratios suggest a stable financial structure. However, efficiency and coverage ratios reveal some areas of concern. Capital expenditure management and dividend policies need attention. The company's liquidity position is strong with good current and cash ratios. Overall, Medplus exhibits sound financial health, but needs to address certain operational inefficiencies and coverage weaknesses to sustain long-term growth and stability. The company's robust performance in growth and profitability is a positive sign for future prospects.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
129.43
Industry Median
55.27
Small Cap Median
55.27
P/E RATIO
36.78
P/B RATIO
4.08
Industry Median
4.08
Small Cap Median
4.08
P/S RATIO
1.14
Industry Median
1.80
Small Cap Median
1.80
Others
PEG RATIO
1.29
EV/EBITDA RATIO
13.02
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹673.05 as on Sep 1, 2026.
Growth Score : 10.00Medplus Health Services demonstrates strong growth across various metrics. High revenue, operating profit, EPS, asset, and net income growth rates indicate robust expansion. This consistent growth reflects effective strategies and market positioning. The company's growth trajectory positions it favorably for future success and market leadership. The company should maintain its effective strategies and market positioning to maintain its growth.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 23.13 | 20.61 | 23.41 | 9.08 | 12.32 |
| Operating Profit Growth Rate | 25.81 | -2.56 | 33.46 | 37.46 | 24.39 |
| Earnings Per Share (EPS) Growth | -99.42 | -48.07 | 31.41 | 129.2 | 45.7 |
| Asset Growth Rate | 65.64 | 7.83 | 7.44 | 11.81 | 17.05 |
| Net Income Growth Rate | 50.79 | -47.37 | 32 | 127.27 | 46.67 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Medplus Health Services Ltd | 7.50 | 36.78 | Neutral | 607.00 | 5.20 | 220.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Concall Report⬤4th Feb 26
Q3 FY26 Earnings Conference Call
BULLISH SENTIMENT
No Stock News Available at This Moment.
Medplus Health Services Ltd is India's second-largest pharmacy retail chain, operating over 4,000 stores across several states. It offers a wide range of pharmaceutical, FMCG, and general merchandise products, alongside diagnostic services. The company leverages an integrated offline-online model to provide convenient and discounted healthcare access to consumers.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Medplus Health Services Ltd's P/E ratio (TTM) is 129.43, compared to the industry median of 55.27 and large cap median of 55.27.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Medplus Health Services Ltd's P/B ratio is 4.08, compared to the industry median of 4.08 and large cap median of 4.08.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Medplus Health Services Ltd's P/S ratio is 1.14, compared to the industry median of 1.80 and large cap median of 1.80.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Medplus Health Services Ltd's PEG ratio is 1.29.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Medplus Health Services Ltd's EV/EBITDA ratio is 13.02.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Medplus Health Services Ltd's ROE is 11.14%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Medplus Health Services Ltd's ROA is 15.43%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Medplus Health Services Ltd's ROCE is 13%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Medplus Health Services Ltd's operating margin is 8.81%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Medplus Health Services Ltd's net margin is 3.19%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Medplus Health Services Ltd's current ratio is 4.33.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Medplus Health Services Ltd's debt-to-equity ratio is 0.72.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Medplus Health Services Ltd's interest coverage ratio is 3.29.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Medplus Health Services Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Medplus Health Services Ltd's EPS is 45.70.
(Source line: "Ratios as of 28 Sept 2026, based on last traded price of ₹673.05. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2006
Headquarters: Hyderabad, Telangana
Core Offerings: Pharmacy Retail, FMCG & General Merchandise, Diagnostic Services, Online Pharmacy Services
Stock Listing: NSE (MEDPLUS), BSE (543427)
Promoter: Gangadi Madhukar Reddy & Promoter Group
Founded in 2006 by Dr. Gangadi Madhukar Reddy, Medplus embarked on a mission to offer genuine medicines at discounted prices. The company rapidly expanded its retail footprint, primarily across South India, establishing itself as a prominent pharmacy chain. A significant milestone was its successful Initial Public Offering (IPO) in December 2021, leading to its listing on the NSE and BSE. Medplus continues to expand its store network and integrate digital offerings to enhance customer experience.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Pharmaceutical Retail | ~80% | Operating Profit |
| Non-Pharmaceutical Retail (FMCG & General Merchandise) | ~15% | Operating Profit |
| Diagnostics & Other Services | ~5% | Operating Profit |
Pharmaceutical Retail: Sells prescription and over-the-counter (OTC) medicines through an extensive network of retail stores and its online platform, emphasizing authenticity and discounts.
FMCG & General Merchandise: Offers a diverse range of fast-moving consumer goods, personal care products, and general merchandise, leveraging the high foot traffic in its pharmacy outlets.
Diagnostics: Operates MedPlus Pathlabs, providing comprehensive diagnostic services including pathology and radiology tests to complement its healthcare offerings.
Online Pharmacy Services: Facilitates medicine ordering and home delivery via the MedPlus Mart app and website, creating an integrated omnichannel retail experience.
Gangadi Madhukar Reddy, Managing Director & CEO. A qualified doctor, he founded Medplus in 2006 and has been the driving force behind its growth to become India's second-largest pharmacy retailer.
Optival Health Solutions Private Limited
MedPlus Pathlabs Private Limited
MedPlus Digital Private Limited
Initial Public Offering (IPO) in December 2021.
The Medplus Health Services Ltd share price today is ₹673.05 on NSE (MEDPLUS), as of 28 Sept 2026.
As of 28 Sept 2026, Medplus Health Services Ltd share price is ₹673.05, with previous close ₹673.05. Today's range is ₹673.05 to ₹673.05. The 52-week range is ₹N/A to ₹N/A.
As of today, Medplus Health Services Ltd's market cap is ₹7,867.95 crore (Mid Cap).
Medplus Health Services Ltd's current P/E ratio is 129.43, compared to the HEALTHCARE EQUIPMENT & SUPPLIES sector average of 36.50.
Medplus Health Services Ltd's current P/B ratio is 4.08.
Medplus Health Services Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
Medplus Health Services Ltd's EPS (TTM) is ₹45.70.
Medplus Health Services Ltd is India's second-largest pharmacy retail chain, operating over 4,000 stores across several states. It offers a wide range of pharmaceutical, FMCG, and general merchandise products, alongside diagnostic services. The company leverages an integrated offline-online model to provide convenient and discounted healthcare access to consumers.
Medplus Health Services Ltd is promoted by Gangadi Madhukar Reddy & Promoter Group, holding 40.22% as of 28 Sept 2026.
Medplus Health Services Ltd is listed on NSE (MEDPLUS) and BSE (543427). Its next quarterly results are expected on August 2024.
Dividend Per Share (DPS)